Opioid receptor agonist Eribis peptide 94 reduces infarct size in different porcine models for myocardial ischaemia and reperfusion

European Journal of Pharmacology

Volumn 651, Issue 1-3, 2011, Pages 146-151

  Karlsson, Lars O ^a   Grip, Lars ^a   Bissessar, Erik ^b   Bobrova, Irina ^b   Gustafsson, Thomas ^c   Kavianipour, Mohammad ^d   Odenstedt, Jacob ^a   Wikström, Gerhard ^d   Gonon, Adrian T ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Eribis Pharmaceuticals AB   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Myocardial ischaemia; Nitric oxide; Opioid receptor; Porcine; Reperfusion injury

Indexed keywords

DELTA OPIATE RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENKEPHALIN DERIVATIVE; ERIBIS PEPTIDE 94; MU OPIATE RECEPTOR; NITRIC OXIDE; OPIATE AGONIST; SERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON OCCLUSION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE MODEL; ENZYME PHOSPHORYLATION; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; IMMUNOHISTOCHEMISTRY; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; TREATMENT OUTCOME;

ANIMALS; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; ENKEPHALINS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMODYNAMICS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE SYNTHASE TYPE III; OPIOID PEPTIDES; RECEPTORS, OPIOID; SWINE;

EID: 78650679360     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.069     Document Type: Article

References (31)

1. Barron B.A., Oakford L.X., Gaugl J.F., and Caffrey J.L. Methionine-enkephalin-Arg-Phe immunoreactivity in heart tissue Peptides 16 1995 1221 1227
2. Bell S.P., Sack M.N., Patel A., Opie L.H., and Yellon D.M. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle J. Am. Coll. Cardiol. 36 2000 2296 2302
3. Cao Z., Liu L., Packwood W., Merkel M., Hurn P.D., and Van Winkle D.M. Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt Am. J. Physiol. Heart Circ. Physiol. 294 2008 H302 H310
4. Council of Europe. 1986. European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (ETS 123). Strasbourg: Council of Europe.
5. Forster K., Kuno A., Solenkova N., Felix S.B., and Krieg T. The delta-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation Am. J. Physiol. Heart Circ. Physiol. 293 2007 H1604 H1608
6. Frassdorf J., Weber N.C., Obal D., Toma O., Mullenheim J., Kojda G., Preckel B., and Schlack W. Morphine induces late cardioprotection in rat hearts in vivo: the involvement of opioid receptors and nuclear transcription factor kappaB Anesth. Analg. 101 2005 934 941 table of contents.
7. Fryer R.M., Wang Y., Hsu A.K., and Gross G.J. Essential activation of PKC-delta in opioid-initiated cardioprotection Am. J. Physiol. Heart Circ. Physiol. 280 2001 H1346 H1353
8. Gonon A.T., Erbas D., Broijersen A., Valen G., and Pernow J. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion Am. J. Physiol. Heart Circ. Physiol. 286 2004 H1767 H1774
9. Gonon A.T., Bulhak A., Labruto F., Sjoquist P.O., and Pernow J. Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide Basic Res. Cardiol. 102 2007 80 89
10. Gonon A.T., Widegren U., Bulhak A., Salehzadeh F., Persson J., Sjoquist P.O., and Pernow J. Adiponectin protects against myocardial ischaemia- reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide Cardiovasc. Res. 78 2008 116 122
11. Gross G.J. Role of opioids in acute and delayed preconditioning J. Mol. Cell. Cardiol. 35 2003 709 718
12. Gross G.J., and Auchampach J.A. Reperfusion injury: does it exist? J. Mol. Cell. Cardiol. 42 2007 12 18
13. Gross E.R., and Gross G.J. Ligand triggers of classical preconditioning and postconditioning Cardiovasc. Res. 70 2006 212 221
14. Gross E.R., Hsu A.K., and Gross G.J. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts Circ. Res. 94 2004 960 966
15. Gross E.R., Peart J.N., Hsu A.K., Auchampach J.A., and Gross G.J. Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway Am. J. Physiol. Heart Circ. Physiol. 288 2005 H2744 H2749
16. Gross E.R., Hsu A.K., Gross G.J., and Basic Res Cardiol GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion Basic Res. Cardiol. 102 2007 341 349
17. Howells R.D., Kilpatrick D.L., Bailey L.C., Noe M., and Udenfriend S. Proenkephalin mRNA in rat heart Proc. Natl Acad. Sci. USA 83 1986 1960 1963
18. Huang M.H., Nguyen V., Wu Y., Rastogi S., Lui C.Y., Birnbaum Y., Wang H.Q., Ware D.L., Chauhan M., Garg N., Poh K.K., Ye L., Omar A.R., Tan H.C., Uretsky B.F., and Fujise K. Reducing ischaemia/reperfusion injury through delta-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signalling Cardiovasc. Res. 84 2009 452 460
19. Huh J., Gross G.J., Nagase H., and Liang B.T. Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels Am. J. Physiol. Heart Circ. Physiol. 280 2001 H377 H383
20. Mayfield K.P., and D'Alecy L.G. Delta-1 opioid agonist acutely increases hypoxic tolerance J. Pharmacol. Exp. Ther. 268 1994 683 688
21. Miki T., Cohen M.V., and Downey J.M. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits Mol. Cell. Biochem. 186 1998 3 12
22. Peart J.N., Gross E.R., Reichelt M.E., Hsu A., Headrick J.P., and Gross G.J. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts Basic Res. Cardiol. 103 2008 454 463
23. Pugsley M.K. The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system Pharmacol. Ther. 93 2002 51 75
24. Schultz J.E., Hsu A.K., and Gross G.J. Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors Circulation 97 1998 1282 1289
25. Sigg D.C., Coles Jr.J.A., Gallagher W.J., Oeltgen P.R., and Iaizzo P.A. Opioid preconditioning: myocardial function and energy metabolism Ann. Thorac. Surg. 72 2001 1576 1582
26. The GUSTO investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N. Engl. J. Med. 329 1993 673 682
27. Tomai F., Crea F., Gaspardone A., Versaci F., Ghini A.S., Ferri C., Desideri G., Chiariello L., and Gioffre P.A. Effects of naloxone on myocardial ischemic preconditioning in humans J. Am. Coll. Cardiol. 33 1999 1863 1869
28. Traynor J.R., and Elliott J. delta-Opioid receptor subtypes and cross-talk with mu-receptors Trends Pharmacol. Sci. 14 1993 84 86
29. Wang G.Y., Wu S., Pei J.M., Yu X.C., and Wong T.M. Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats Am. J. Physiol. Heart Circ. Physiol. 280 2001 H384 H391
30. Watson M.J., Holt J.D., O'Neill S.J., Wei K., Pendergast W., Gross G.J., Gengo P.J., and Chang K.J. ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl) (3-hydroxyphenyl)methyl)-2,5-d imethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects J. Pharmacol. Exp. Ther. 316 2006 423 430
31. Yellon D.M., and Hausenloy D.J. Myocardial reperfusion injury N. Engl. J. Med. 357 2007 1121 1135